{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:24:16Z","timestamp":1790976256585,"version":"4.1.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100030692","name":"Intramural Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Immune processes play complex roles in Alzheimer\u2019s disease and related dementias (ADRD), but it remains unclear whether host defenses against common microbes also contribute to ADRD, and what underlying mechanisms may account for these relationships. Using antibody and plasma proteomic data from the Monongahela-Youghiogheny Healthy Aging Team study (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20091,003; mean age\u2009=\u200978.0 yrs; follow up 7.6 yrs), the present study detected accelerated decline across a variety of cognitive domains and altered plasma abundance of FLT1 (also known as Vascular Endothelial Growth Factor Receptor 1) among participants with elevated cytomegalovirus (CMV) titers. After analyses in the Baltimore Longitudinal Study of Aging (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009323) and the UK Biobank (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009956) revealed CMV titer associations with higher cross-sectional cognition and greater cognitive decline were moderated by plasma FLT1 abundance, we leveraged two-sample Mendelian Randomization to uncover causal roles for host immune responses to CMV, including limiting brain amyloidosis. Using multi-cohort proteomic signatures of CMV antibody levels and plasma FLT1, bioinformatic analyses suggested that host immune responses to CMV may impact neurologic health through alterations in lymphocytic immunoregulatory cascades, with circulating FLT1 abundance capturing the extent to which these effects may be transmitted across the blood\u2013brain-barrier. In addition to detecting pleiotropic associations of CMV titers with neurocognitive outcomes, our findings highlight FLT1 as an important molecular moderator of these effects, and extend our understanding of the biological basis by which host immune responses to common microbes may contribute to ADRD.\n                  <\/jats:p>","DOI":"10.1186\/s12974-026-03800-8","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T12:07:58Z","timestamp":1776341278000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CMV titer associations with cognition and the plasma proteome implicate FLT1 and neurovascular mechanisms as potential moderators"],"prefix":"10.1186","volume":"23","author":[{"given":"Michael R.","family":"Duggan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuojia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridhar","family":"Kandala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra M.","family":"Joynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas K.","family":"Karikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishwajit L.","family":"Nimgaonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Ilyas","family":"Kamboh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth E.","family":"Snitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Ferrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Yolken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Ganguli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keenan A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"3800_CR1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41582-021-00549-x","volume":"17","author":"BM Bettcher","year":"2021","unstructured":"Bettcher BM, Tansey MG, Doroth\u00e9e G, Heneka MT. Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus. Nat Rev Neurol. 2021;17:689\u2013701.","journal-title":"Nat Rev Neurol"},{"key":"3800_CR2","first-page":"792","volume":"140","author":"Z Fan","year":"2017","unstructured":"Fan Z, Brooks DJ, Okello A, Edison P. An early and late peak in microglial activation in Alzheimer\u2019s disease trajectory. Brain. 2017;140:792\u2013803.","journal-title":"Brain"},{"key":"3800_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S1474-4422(22)00027-8","volume":"21","author":"E Morenas-Rodr\u00edguez","year":"2022","unstructured":"Morenas-Rodr\u00edguez E, et al. Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer\u2019s disease: a longitudinal observational study. Lancet Neurol. 2022;21:329\u201341.","journal-title":"Lancet Neurol"},{"key":"3800_CR4","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/alz.12399","volume":"18","author":"HS Yang","year":"2022","unstructured":"Yang HS, et al. Plasma IL-12\/IFN-\u03b3 axis predicts cognitive trajectories in cognitively unimpaired older adults. Alzheimers Dement. 2022;18:645\u201353.","journal-title":"Alzheimers Dement"},{"key":"3800_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s12035-014-8657-1","volume":"50","author":"F Brosseron","year":"2014","unstructured":"Brosseron F, Krauthausen M, Kummer M, Heneka MT. Body fluid cytokine levels in mild cognitive impairment and Alzheimer\u2019s disease: a comparative overview. Mol Neurobiol. 2014;50:534\u201344.","journal-title":"Mol Neurobiol"},{"key":"3800_CR6","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000201036","author":"MR Duggan","year":"2022","unstructured":"Duggan MR, et al. Herpes viruses in the Baltimore longitudinal study of aging: associations with brain volumes, cognitive performance, and plasma biomarkers. Neurology. 2022. https:\/\/doi.org\/10.1212\/WNL.0000000000201036.","journal-title":"Neurology"},{"key":"3800_CR7","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/S1473-3099(21)00144-4","volume":"21","author":"PN Sipil\u00e4","year":"2021","unstructured":"Sipil\u00e4 PN, et al. Hospital-treated infectious diseases and the risk of dementia: a large, multicohort, observational study with a replication cohort. Lancet Infect Dis. 2021;21:1557\u201367.","journal-title":"Lancet Infect Dis"},{"key":"3800_CR8","doi-asserted-by":"publisher","first-page":"eadt7176","DOI":"10.1126\/sciadv.adt7176","volume":"11","author":"MR Duggan","year":"2025","unstructured":"Duggan MR, et al. Proteomic signatures of corona and herpes viral antibodies identify IGDCC4 as a mediator of neurodegeneration. Sci Adv. 2025;11:eadt7176.","journal-title":"Sci Adv"},{"key":"3800_CR9","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3233\/JAD-130977","volume":"38","author":"R Mancuso","year":"2014","unstructured":"Mancuso R, et al. Titers of herpes simplex virus type 1 antibodies positively correlate with grey matter volumes in Alzheimer\u2019s disease. J Alzheimers Dis. 2014;38:741\u20135.","journal-title":"J Alzheimers Dis"},{"key":"3800_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41583-019-0255-9","volume":"21","author":"JV Pluvinage","year":"2020","unstructured":"Pluvinage JV, Wyss-Coray T. Systemic factors as mediators of brain homeostasis, ageing and neurodegeneration. Nat Rev Neurosci. 2020;21:93\u2013102.","journal-title":"Nat Rev Neurosci"},{"key":"3800_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-024-00682-4","author":"MR Duggan","year":"2024","unstructured":"Duggan MR, et al. Proteomics identifies potential immunological drivers of postinfection brain atrophy and cognitive decline. Nature Aging. 2024. https:\/\/doi.org\/10.1038\/s43587-024-00682-4.","journal-title":"Nature Aging"},{"key":"3800_CR12","doi-asserted-by":"publisher","first-page":"108526","DOI":"10.1016\/j.isci.2023.108526","volume":"26","author":"MA Beydoun","year":"2023","unstructured":"Beydoun MA, et al. Hospital-treated prevalent infections, the plasma proteome and incident dementia among UK older adults. iScience. 2023;26:108526.","journal-title":"iScience"},{"key":"3800_CR13","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41593-024-01576-9","volume":"27","author":"C Greene","year":"2024","unstructured":"Greene C, et al. Blood\u2013brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci. 2024;27:421\u201332.","journal-title":"Nat Neurosci"},{"key":"3800_CR14","doi-asserted-by":"publisher","first-page":"eadf5681","DOI":"10.1126\/scitranslmed.adf5681","volume":"15","author":"KA Walker","year":"2023","unstructured":"Walker KA, et al. Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later life. Sci Transl Med. 2023;15:eadf5681.","journal-title":"Sci Transl Med."},{"key":"3800_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13024-023-00627-2","volume":"18","author":"KA Walker","year":"2023","unstructured":"Walker KA, et al. The role of peripheral inflammatory insults in Alzheimer\u2019s disease: a review and research roadmap. Mol Neurodegener. 2023;18:37.","journal-title":"Mol Neurodegener"},{"key":"3800_CR16","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3233\/JAD-200814","volume":"78","author":"MR Duggan","year":"2020","unstructured":"Duggan MR, Torkzaban B, Ahooyi TM, Khalili K. Potential role for Herpesviruses in Alzheimer\u2019s disease. J Alzheimers Dis. 2020;78:855\u201369.","journal-title":"J Alzheimers Dis"},{"key":"3800_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/WAD.0b013e3181f73bc2","volume":"25","author":"OY Kusbeci","year":"2011","unstructured":"Kusbeci OY, Miman O, Yaman M, Aktepe OC, Yazar S. Could Toxoplasma gondii have any role in Alzheimer disease? Alzheimer Dis Assoc Disord. 2011;25:1\u20133.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"3800_CR18","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/gps.2257","volume":"24","author":"M Ganguli","year":"2009","unstructured":"Ganguli M, Snitz B, Vander Bilt J, Chang CC. How much do depressive symptoms affect cognition at the population level? The Monongahela-Youghiogheny Healthy Aging Team (MYHAT) study. Int J Geriatr Psychiatry. 2009;24:1277\u201384.","journal-title":"Int J Geriatr Psychiatry"},{"key":"3800_CR19","volume-title":"Normal human aging: The Baltimore longitudinal study of aging","author":"NW Shock","year":"1984","unstructured":"Shock NW, et al. Normal human aging: The Baltimore longitudinal study of aging. Washington, D.C.: National Institutes of Health; 1984."},{"key":"3800_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft C, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203\u20139.","journal-title":"Nature"},{"key":"3800_CR21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E von Elm","year":"2007","unstructured":"von Elm E, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147:573\u20137.","journal-title":"Ann Intern Med"},{"key":"3800_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/wad.0000000000000133","author":"VL Nimgaonkar","year":"2016","unstructured":"Nimgaonkar VL, et al. Temporal cognitive decline associated with exposure to infectious agents in a population-based, aging cohort. Alzheimer Dis Assoc Disord. 2016. https:\/\/doi.org\/10.1097\/wad.0000000000000133.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"3800_CR23","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1038\/s41467-022-29307-3","volume":"13","author":"AJ Mentzer","year":"2022","unstructured":"Mentzer AJ, et al. Identification of host\u2013pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank. Nat Commun. 2022;13:1818.","journal-title":"Nat Commun"},{"key":"3800_CR24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13024-024-00753-5","volume":"19","author":"X Zeng","year":"2024","unstructured":"Zeng X, et al. Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer\u2019s disease. Mol Neurodegener. 2024;19:68.","journal-title":"Mol Neurodegener"},{"key":"3800_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun BB, et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature. 2023;622:329\u201338.","journal-title":"Nature"},{"key":"3800_CR26","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1038\/s41591-025-03834-0","volume":"31","author":"F Imam","year":"2025","unstructured":"Imam F, et al. The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging. Nat Med. 2025;31:2556\u201366.","journal-title":"Nat Med"},{"key":"3800_CR27","doi-asserted-by":"publisher","first-page":"7238","DOI":"10.1038\/s41467-023-42834-x","volume":"14","author":"W Feng","year":"2023","unstructured":"Feng W, et al. NULISA: a proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing. Nat Commun. 2023;14:7238.","journal-title":"Nat Commun"},{"key":"3800_CR28","doi-asserted-by":"publisher","first-page":"17147","DOI":"10.1038\/s41598-022-22116-0","volume":"12","author":"J Candia","year":"2022","unstructured":"Candia J, Daya GN, Tanaka T, Ferrucci L, Walker KA. Assessment of variability in the plasma 7k SomaScan proteomics assay. Sci Rep. 2022;12:17147.","journal-title":"Sci Rep"},{"key":"3800_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2021.100168","author":"L Wik","year":"2021","unstructured":"Wik L, et al. Proximity extension assay in combination with next-generation sequencing for high-throughput proteome-wide analysis. Mol Cell Proteomics. 2021. https:\/\/doi.org\/10.1016\/j.mcpro.2021.100168.","journal-title":"Mol Cell Proteomics"},{"key":"3800_CR30","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1080\/13607860903071014","volume":"14","author":"M Ganguli","year":"2010","unstructured":"Ganguli M, et al. Age and education effects and norms on a cognitive test battery from a population-based cohort: the Monongahela-Youghiogheny Healthy Aging Team. Aging Ment Health. 2010;14:100\u20137.","journal-title":"Aging Ment Health"},{"key":"3800_CR31","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10654-019-00499-1","volume":"34","author":"T Wilkinson","year":"2019","unstructured":"Wilkinson T, et al. Identifying dementia outcomes in UK Biobank: a validation study of primary care, hospital admissions and mortality data. Eur J Epidemiol. 2019;34:557\u201365.","journal-title":"Eur J Epidemiol"},{"key":"3800_CR32","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.neuroimage.2015.11.073","volume":"127","author":"J Doshi","year":"2016","unstructured":"Doshi J, et al. MUSE: multi-atlas region segmentation utilizing ensembles of registration algorithms and parameters, and locally optimal atlas selection. Neuroimage. 2016;127:186\u201395.","journal-title":"Neuroimage"},{"key":"3800_CR33","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1006\/nimg.2001.0937","volume":"14","author":"C Davatzikos","year":"2001","unstructured":"Davatzikos C, Genc A, Xu D, Resnick SM. Voxel-based morphometry using the RAVENS maps: methods and validation using simulated longitudinal atrophy. Neuroimage. 2001;14:1361\u20139.","journal-title":"Neuroimage"},{"key":"3800_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03144-x","author":"Z Yang","year":"2024","unstructured":"Yang Z, et al. Brain aging patterns in a large and diverse cohort of 49,482 individuals. Nat Med. 2024. https:\/\/doi.org\/10.1038\/s41591-024-03144-x.","journal-title":"Nat Med"},{"key":"3800_CR35","doi-asserted-by":"publisher","unstructured":"Bilgel M, An Y, Walker KA, Moghekar AR, Ashton NJ, KacPR, Karikari TK, Blennow K, Zetterberg H, Jedynak BM, Thambisetty M, Ferrucci L, Resnick SM. Longitudinal changes in Alzheimer's-relatedplasma biomarkers and brain amyloid. Alzheimers Dement. 2023;19(10):4335\u201345. https:\/\/doi.org\/10.1002\/alz.13157. Epub 2023 May 22. PMID:37216632; PMCID: PMC10592628.","DOI":"10.1002\/alz.13157"},{"key":"3800_CR36","doi-asserted-by":"publisher","unstructured":"Butler-Laporte G, Kreuzer D, Nakanishi T, Harroud A, Forgetta V, Richards JB. Genetic determinants of antibody-mediated immune responses toInfectious diseases agents: a genome-wide and HLA association study. Open Forum Infect Dis. 2020;7(11):ofaa450. https:\/\/doi.org\/10.1093\/ofid\/ofaa450. PMID: 33204752; PMCID: PMC7641500.","DOI":"10.1093\/ofid\/ofaa450"},{"key":"3800_CR37","doi-asserted-by":"publisher","unstructured":"Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI,Styrmisdottir EL, Gunnarsdottir K, Helgason A, Oddsson A, Halldorsson BV, Jensson BO, Zink F, Halldorsson GH, Masson G, Arnadottir GA,Katrinardottir H, Juliusson K, Magnusson MK, Magnusson OT, Fridriksdottir R, Saevarsdottir S, Gudjonsson SA, Stacey SN, Rognvaldsson S,Eiriksdottir T, Olafsdottir TA, Steinthorsdottir V, Tragante V, Ulfarsson MO, Stefansson H, Jonsdottir I, Holm H, Rafnar T, Melsted P, SaemundsdottirJ, Norddahl GL, Lund SH, Gudbjartsson DF, Thorsteinsdottir U, Stefansson K. Large-scale integration of the plasma proteome with genetics anddisease. Nat Genet. 2021;53(12):1712\u201321. https:\/\/doi.org\/10.1038\/s41588-021-00978-w. Epub 2021 Dec 2. PMID: 34857953.","DOI":"10.1038\/s41588-021-00978-w"},{"key":"3800_CR38","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat Genet. 2019;51:414\u201330.","journal-title":"Nat Genet"},{"key":"3800_CR39","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613:508\u201318.","journal-title":"Nature"},{"key":"3800_CR40","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/s41588-018-0147-3","volume":"50","author":"JJ Lee","year":"2018","unstructured":"Lee JJ, et al. Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. Nat Genet. 2018;50:1112\u201321.","journal-title":"Nat Genet."},{"key":"3800_CR41","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40478-023-01563-4","volume":"11","author":"M Ali","year":"2023","unstructured":"Ali M, et al. Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease. Acta Neuropathol Commun. 2023;11:68.","journal-title":"Acta Neuropathol Commun"},{"key":"3800_CR42","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41586-023-06802-1","volume":"624","author":"HS-H Oh","year":"2023","unstructured":"Oh HS-H, et al. Organ aging signatures in the plasma proteome track health and disease. Nature. 2023;624:164\u201372.","journal-title":"Nature"},{"key":"3800_CR43","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1161\/STROKEAHA.123.043908","volume":"54","author":"J Cordon","year":"2023","unstructured":"Cordon J, et al. Identification of clinically relevant brain endothelial cell biomarkers in plasma. Stroke. 2023;54:2853\u201363.","journal-title":"Stroke"},{"key":"3800_CR44","doi-asserted-by":"publisher","first-page":"D808","DOI":"10.1093\/nar\/gks1094","volume":"41","author":"A Franceschini","year":"2013","unstructured":"Franceschini A, et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013;41:D808-815.","journal-title":"Nucleic Acids Res"},{"key":"3800_CR45","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013;14:128.","journal-title":"BMC Bioinformatics"},{"key":"3800_CR46","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1128\/CVI.00124-08","volume":"15","author":"EG Severance","year":"2008","unstructured":"Severance EG, et al. Development of a nucleocapsid-based human coronavirus immunoassay and estimates of individuals exposed to coronavirus in a U.S. metropolitan population. Clin Vaccine Immunol. 2008;15:1805\u201310.","journal-title":"Clin Vaccine Immunol"},{"key":"3800_CR47","doi-asserted-by":"publisher","first-page":"e0274872","DOI":"10.1371\/journal.pone.0274872","volume":"17","author":"K Mekli","year":"2022","unstructured":"Mekli K, et al. Investigation of the association between the antibody responses to neurotropic viruses and dementia outcomes in the UK Biobank. PLoS ONE. 2022;17:e0274872.","journal-title":"PLoS ONE"},{"key":"3800_CR48","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/path.4437","volume":"235","author":"P Griffiths","year":"2015","unstructured":"Griffiths P, Baraniak I, Reeves M. The pathogenesis of human cytomegalovirus. J Pathol. 2015;235:288\u201397.","journal-title":"J Pathol"},{"key":"3800_CR49","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-025-02249-0","volume":"10","author":"C Lee","year":"2025","unstructured":"Lee C, et al. Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives. Signal Transduct Target Ther. 2025;10:170.","journal-title":"Signal Transduct Target Ther"},{"key":"3800_CR50","doi-asserted-by":"publisher","first-page":"e14413","DOI":"10.1002\/alz.14413","volume":"21","author":"L Ibanez","year":"2025","unstructured":"Ibanez L, et al. Benchmarking of a multi-biomarker low-volume panel for Alzheimer\u2019s disease and related dementia research. Alzheimers Dement. 2025;21:e14413.","journal-title":"Alzheimers Dement"},{"key":"3800_CR51","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.cell.2024.10.045","volume":"188","author":"YT Deng","year":"2025","unstructured":"Deng YT, et al. Atlas of the plasma proteome in health and disease in 53,026 adults. Cell. 2025;188:253-271.e257.","journal-title":"Cell"},{"key":"3800_CR52","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41586-023-06563-x","volume":"622","author":"GH Eldjarn","year":"2023","unstructured":"Eldjarn GH, et al. Large-scale plasma proteomics comparisons through genetics and disease associations. Nature. 2023;622:348\u201358.","journal-title":"Nature"},{"key":"3800_CR53","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12883-025-04279-1","volume":"25","author":"M Vacher","year":"2025","unstructured":"Vacher M, et al. Relationship between cytomegalovirus antibody levels and cognitive performance is dependent on age and genetic risk. BMC Neurol. 2025;25:270.","journal-title":"BMC Neurol"},{"key":"3800_CR54","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/infdis\/jiu437","volume":"211","author":"LL Barnes","year":"2015","unstructured":"Barnes LL, et al. Cytomegalovirus infection and risk of Alzheimer disease in older black and white individuals. J Infect Dis. 2015;211:230\u20137.","journal-title":"J Infect Dis"},{"key":"3800_CR55","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1038\/s41598-019-41218-w","volume":"9","author":"C Warren-Gash","year":"2019","unstructured":"Warren-Gash C, et al. Human herpesvirus infections and dementia or mild cognitive impairment: a systematic review and meta-analysis. Sci Rep. 2019;9:4743.","journal-title":"Sci Rep"},{"key":"3800_CR56","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1001\/jama.2025.5013","volume":"333","author":"M Pomirchy","year":"2025","unstructured":"Pomirchy M, et al. Herpes zoster vaccination and dementia occurrence. JAMA. 2025;333:2083\u201392.","journal-title":"JAMA"},{"key":"3800_CR57","doi-asserted-by":"publisher","first-page":"113207","DOI":"10.1016\/j.bbr.2021.113207","volume":"405","author":"MR Duggan","year":"2021","unstructured":"Duggan MR, Parikh V. Microglia and modifiable life factors: potential contributions to cognitive resilience in aging. Behav Brain Res. 2021;405:113207.","journal-title":"Behav Brain Res"},{"key":"3800_CR58","doi-asserted-by":"crossref","unstructured":"Momkus J, et al. A Pathogen Penalty? Associations between persistent infections and biological aging in the US. J Infect Dis. 2025:jiaf606.","DOI":"10.1093\/infdis\/jiaf606"},{"key":"3800_CR59","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12979-018-0120-0","volume":"15","author":"F-J Yang","year":"2018","unstructured":"Yang F-J, et al. Anti-cytomegalovirus IgG antibody titer is positively associated with advanced T cell differentiation and coronary artery disease in end-stage renal disease. Immunity Ageing. 2018;15:15.","journal-title":"Immunity Ageing"},{"key":"3800_CR60","first-page":"683.e681","volume":"27","author":"S Kawamura","year":"2021","unstructured":"Kawamura S, et al. Prediction of cytomegalovirus reactivation by recipient cytomegalovirus-IgG Titer before allogeneic hematopoietic stem cell transplantation. Transplant Cell Ther. 2021;27:683.e681-683.e687.","journal-title":"Transplant Cell Ther"},{"key":"3800_CR61","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s11357-011-9205-9","volume":"33","author":"SX Leng","year":"2011","unstructured":"Leng SX, et al. Relationship between cytomegalovirus (CMV) IgG serology, detectable CMV DNA in peripheral monocytes, and CMV pp65495\u2013503-specific CD8+ T cells in older adults. Age. 2011;33:607\u201314.","journal-title":"Age"},{"key":"3800_CR62","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1007\/s11357-024-01124-0","volume":"46","author":"M Watanabe","year":"2024","unstructured":"Watanabe M, et al. Anti-cytomegalovirus antibody levels stratify human immune profiles across the lifespan. Geroscience. 2024;46:4225\u201342.","journal-title":"Geroscience"},{"key":"3800_CR63","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.4049\/jimmunol.2200369","volume":"209","author":"JA Breznik","year":"2022","unstructured":"Breznik JA, et al. cytomegalovirus seropositivity in older adults changes the t cell repertoire but does not prevent antibody or cellular responses to SARS-CoV-2 vaccination. J Immunol. 2022;209:1892\u2013905.","journal-title":"J Immunol"},{"key":"3800_CR64","doi-asserted-by":"publisher","unstructured":"Hobson R, Levy SHS, Singal CMS, Flaherty D, Xiao H, Ciener B, Reddy H, Zabinyakov N, Kim CY, Teich AF,Shneider NA, Bradshaw EM, Elyaman W. Clonal CD8+ T cells populate the leptomeninges and coordinate with immune cells in humandegenerative brain diseases. Nat Immunol. 2026;27(2):323\u201335. https:\/\/doi.org\/10.1038\/s41590-025-02401-6. Epub 2026 Jan 27. PMID: 41593242;PMCID: PMC12864034.","DOI":"10.1038\/s41590-025-02401-6"},{"key":"3800_CR65","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bbi.2020.05.070","volume":"89","author":"MS Unger","year":"2020","unstructured":"Unger MS, et al. CD8+ T-cells infiltrate Alzheimer\u2019s disease brains and regulate neuronal- and synapse-related gene expression in APP-PS1 transgenic mice. Brain Behav Immun. 2020;89:67\u201386.","journal-title":"Brain Behav Immun"},{"key":"3800_CR66","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/s41593-023-01415-3","volume":"26","author":"M Jorfi","year":"2023","unstructured":"Jorfi M, et al. Infiltrating CD8(+) T cells exacerbate Alzheimer\u2019s disease pathology in a 3D human neuroimmune axis model. Nat Neurosci. 2023;26:1489\u2013504.","journal-title":"Nat Neurosci"},{"key":"3800_CR67","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/s41593-022-01183-6","volume":"25","author":"T Kaya","year":"2022","unstructured":"Kaya T, et al. CD8+ T cells induce interferon-responsive oligodendrocytes and microglia in white matter aging. Nat Neurosci. 2022;25:1446\u201357.","journal-title":"Nat Neurosci"},{"key":"3800_CR68","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neuron.2018.06.030","volume":"99","author":"WA Eimer","year":"2018","unstructured":"Eimer WA, et al. Alzheimer\u2019s disease-associated \u03b2-amyloid is rapidly seeded by Herpesviridae to protect against brain infection. Neuron. 2018;99:56-63.e53.","journal-title":"Neuron"},{"key":"3800_CR69","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S1474-4422(17)30077-7","volume":"16","author":"CR Jack Jr.","year":"2017","unstructured":"Jack CR Jr., et al. Age-specific and sex-specific prevalence of cerebral \u03b2-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study. Lancet Neurol. 2017;16:435\u201344.","journal-title":"Lancet Neurol"},{"key":"3800_CR70","doi-asserted-by":"publisher","first-page":"7614","DOI":"10.1074\/jbc.M009705200","volume":"276","author":"I Kim","year":"2001","unstructured":"Kim I, et al. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-B activation in endothelial cells. J Biol Chem. 2001;276:7614\u201320.","journal-title":"J Biol Chem"},{"key":"3800_CR71","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.it.2005.07.004","volume":"26","author":"B Engelhardt","year":"2005","unstructured":"Engelhardt B, Ransohoff RM. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol. 2005;26:485\u201395.","journal-title":"Trends Immunol"},{"key":"3800_CR72","doi-asserted-by":"publisher","first-page":"17629","DOI":"10.1074\/jbc.271.30.17629","volume":"271","author":"M Clauss","year":"1996","unstructured":"Clauss M, et al. The vascular endothelial growth factor receptor Flt-1 mediates biological activities: implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem. 1996;271:17629\u201334.","journal-title":"J Biol Chem"},{"key":"3800_CR73","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1182\/blood.V87.8.3336.bloodjournal8783336","volume":"87","author":"B Barleon","year":"1996","unstructured":"Barleon B, et al. Migration of human monocytes in response to Vascular Endothelial Growth Factor (VEGF) Is mediated via the VEGF Receptor flt-1. Blood. 1996;87:3336\u201343.","journal-title":"Blood"},{"key":"3800_CR74","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1161\/ATVBAHA.107.150433","volume":"28","author":"M Murakami","year":"2008","unstructured":"Murakami M, et al. VEGFR1 tyrosine kinase signaling promotes lymphangiogenesis as well as angiogenesis indirectly via macrophage recruitment. Arterioscler Thromb Vasc Biol. 2008;28:658\u201364.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3800_CR75","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.biopha.2018.12.021","volume":"111","author":"T Betto","year":"2019","unstructured":"Betto T, et al. Vascular endothelial growth factor receptor 1 tyrosine kinase signaling facilitates healing of DSS-induced colitis by accumulation of Tregs in ulcer area. Biomed Pharmacother. 2019;111:131\u201341.","journal-title":"Biomed Pharmacother"},{"key":"3800_CR76","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1161\/CIRCRESAHA.109.210963","volume":"107","author":"J Zhang","year":"2010","unstructured":"Zhang J, et al. VEGF blockade inhibits lymphocyte recruitment and ameliorates immune-mediated vascular remodeling. Circ Res. 2010;107:408\u201317.","journal-title":"Circ Res"},{"key":"3800_CR77","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/brain\/awv408","volume":"139","author":"C Dansokho","year":"2016","unstructured":"Dansokho C, et al. Regulatory T cells delay disease progression in Alzheimer-like pathology. Brain. 2016;139:1237\u201351.","journal-title":"Brain"},{"key":"3800_CR78","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV. Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14:133\u201350.","journal-title":"Nat Rev Neurol"},{"key":"3800_CR79","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1172\/JCI17189","volume":"111","author":"SE Maynard","year":"2003","unstructured":"Maynard SE, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649\u201358.","journal-title":"J Clin Invest"},{"key":"3800_CR80","doi-asserted-by":"publisher","first-page":"15699","DOI":"10.1038\/ncomms15699","volume":"8","author":"JM Boucher","year":"2017","unstructured":"Boucher JM, et al. Dynamic alterations in decoy VEGF receptor-1 stability regulate angiogenesis. Nat Commun. 2017;8:15699.","journal-title":"Nat Commun"},{"key":"3800_CR81","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.0808698106","volume":"106","author":"AT Argaw","year":"2009","unstructured":"Argaw AT, Gurfein BT, Zhang Y, Zameer A, John GR. VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci U S A. 2009;106:1977\u201382.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3800_CR82","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/s41593-023-01415-3","volume":"26","author":"M Jorfi","year":"2023","unstructured":"Jorfi M, et al. Infiltrating CD8+ T cells exacerbate Alzheimer\u2019s disease pathology in a 3D human neuroimmune axis model. Nat Neurosci. 2023;26:1489\u2013504.","journal-title":"Nat Neurosci"},{"key":"3800_CR83","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/ana.410190411","volume":"19","author":"ET Hedley-Whyte","year":"1986","unstructured":"Hedley-Whyte ET, Hsu DW. Effect of dexamethasone on blood-brain barrier in the normal mouse. Ann Neurol. 1986;19:373\u20137.","journal-title":"Ann Neurol"},{"key":"3800_CR84","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/356063a0","volume":"356","author":"TA Yednock","year":"1992","unstructured":"Yednock TA, et al. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature. 1992;356:63\u20136.","journal-title":"Nature"},{"key":"3800_CR85","doi-asserted-by":"publisher","unstructured":"Otsuka S, Melis N, Gaida MM, Dutta D, Weigert R, Ashwell JD. Calcineurin inhibitors suppress acute graft-versus-hostdisease via NFAT-independent inhibition of T cell receptor signaling. J Clin Invest. 2021;131(11):e147683. https:\/\/doi.org\/10.1172\/JCI147683. PMID:33822776; PMCID: PMC8159692.","DOI":"10.1172\/JCI147683"},{"key":"3800_CR86","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1002\/jcp.29248","volume":"235","author":"M Duggan","year":"2020","unstructured":"Duggan M, Torkzaban B, Ahooyi TM, Khalili K, Gordon J. Age-related neurodegenerative diseases. J Cell Physiol. 2020;235:3131\u201341.","journal-title":"J Cell Physiol"},{"key":"3800_CR87","doi-asserted-by":"publisher","first-page":"106233","DOI":"10.1016\/j.bbi.2025.106233","volume":"132","author":"MR Duggan","year":"2026","unstructured":"Duggan MR, et al. Can the COVID-19 pandemic advance neuroinfectious research? Brain Behav Immun. 2026;132:106233.","journal-title":"Brain Behav Immun"},{"key":"3800_CR88","unstructured":"Mocarski ES, Shenk T, Griffiths PD, Pass RF. Cytomegaloviruses. in Fields Virology, Vol. 1 (eds. Knipe, D.M. & Howley, P.M.) (Wolters Kluwer. , Philadelphia, PA, USA, 2013."},{"key":"3800_CR89","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.humimm.2004.02.008","volume":"65","author":"WJ Britt","year":"2004","unstructured":"Britt WJ, Boppana S. Human cytomegalovirus virion proteins. Hum Immunol. 2004;65:395\u2013402.","journal-title":"Hum Immunol"},{"key":"3800_CR90","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.bbi.2022.10.019","volume":"107","author":"GA Noppert","year":"2023","unstructured":"Noppert GA, Stebbins RC, Dowd JB, Aiello AE. Socioeconomic and race\/ethnic differences in immunosenescence: evidence from the Health and Retirement Study. Brain Behav Immun. 2023;107:361\u20138.","journal-title":"Brain Behav Immun"},{"key":"3800_CR91","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41577-020-0348-8","volume":"20","author":"EP Scully","year":"2020","unstructured":"Scully EP, Haverfield J, Ursin RL, Tannenbaum C, Klein SL. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immunol. 2020;20:442\u20137.","journal-title":"Nat Rev Immunol"},{"key":"3800_CR92","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/13872877241283823","volume":"102","author":"LM Besser","year":"2024","unstructured":"Besser LM, Fuentes AJ, Zhang JN, O\u2019Shea DM, Galvin JE. Intersectionality of gender with social determinants of health and asymptomatic Alzheimer\u2019s disease neuropathology. J Alzheimers Dis. 2024;102:110\u20138.","journal-title":"J Alzheimers Dis"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-026-03800-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03800-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-026-03800-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:12:40Z","timestamp":1781647960000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-026-03800-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3800"],"URL":"https:\/\/doi.org\/10.1186\/s12974-026-03800-8","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"9 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The MYHAT protocols were approved by the Institutional Review Board (IRB) of the University of Pittsburgh (19020264, 19040058). The BLSA protocol was approved by the IRB of the National Institute of Environmental Health Science, National Institutes of Health (03AG0325). GNPC protocols were approved by each cohort\u2019s respective IRBs. The UKB protocol was approved by the National Health Service National Research Ethics Service (11\/NW\/0382). Informed consent was obtained from all participants and deidentified data were used for analyses. The current analyses were conducted in accordance with previously approved IRB protocol guidelines and were exempt from additional approval, consistent with analyses leveraging deidentified observational cohort data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KAW is an Associate Editor at Alzheimer\u2019s & Dementia, a member of the Editorial Board of Annals of Clinical and Translational Neurology, and on the Board of Directors of the National Academy of Neuropsychology. KAW has given unpaid presentations and seminars on behalf of SomaLogic. KAW is a co-founder of Centia Bio. The work presented in this manuscript was conducted independently of Centia Bio and without financial support from the company. All analyses were performed in academic and\/or government research settings. TKK has served as a consultant to Quanterix Corporation. The remaining authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"169"}}